erythrosine has been researched along with Leukemia, Myeloid in 24 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In one patient with acute megakaryoblastic leukemia, GM-CSF caused parallel increases in labelling index, Ki-67 positivity and numbers of nucleoside transporters on peripheral blood blast cells." | 2.67 | Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter. ( Biggs, JC; Cebon, JS; Gibson, J; Jamieson, GP; McKendrick, JJ; Sheridan, WP; Snook, MB; Szer, J; Wiley, JS; Woodruff, RK, 1994) |
| "KY01 myelogenous leukemia cells treated in this way accumulated over 100-fold higher intracellular levels of oligodeoxynucleotides than in the absence of streptolysin O and, in contrast to the latter case, were observed to concentrate internalized molecules in their nuclei." | 1.29 | Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O. ( Spiller, DG; Tidd, DM, 1995) |
| "Cycloheximide treatment was found to cause a significant decrease in c-myc oncoprotein content within 2 h (P less than 0." | 1.28 | Simultaneous quantification of c-myc oncoprotein, total cellular protein, and DNA content using multiparameter flow cytometry. ( Bauer, KD; Engelhard, HH; Krupka, JL, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakubikova, J | 1 |
| Duraj, J | 1 |
| Hunakova, L | 1 |
| Chorvath, B | 1 |
| Sedlak, J | 1 |
| FINK, MA | 1 |
| MALMGREN, RA | 1 |
| RAUSCHER, FJ | 1 |
| ORR, HC | 1 |
| KARON, M | 1 |
| Munce, NR | 1 |
| Li, J | 1 |
| Herman, PR | 1 |
| Lilge, L | 1 |
| Stoddart, RW | 1 |
| Collins, RD | 1 |
| Jacobson, W | 1 |
| O'Keefe, D | 1 |
| Ashman, L | 1 |
| Spiller, DG | 1 |
| Tidd, DM | 1 |
| Wiley, JS | 2 |
| Cebon, JS | 1 |
| Jamieson, GP | 2 |
| Szer, J | 1 |
| Gibson, J | 1 |
| Woodruff, RK | 1 |
| McKendrick, JJ | 1 |
| Sheridan, WP | 1 |
| Biggs, JC | 1 |
| Snook, MB | 2 |
| Maresh, GA | 1 |
| Monnat, RJ | 1 |
| Brocklebank, AM | 1 |
| Sawyer, WH | 1 |
| Buolamwini, JK | 1 |
| Paterson, AR | 1 |
| Lotem, J | 1 |
| Peled-Kamar, M | 1 |
| Groner, Y | 1 |
| Sachs, L | 1 |
| Legrand, O | 2 |
| Simonin, G | 2 |
| Perrot, JY | 1 |
| Zittoun, R | 2 |
| Marie, JP | 2 |
| van der Kolk, DM | 1 |
| de Vries, EG | 1 |
| van Putten, WJ | 1 |
| Verdonck, LF | 1 |
| Ossenkoppele, GJ | 1 |
| Verhoef, GE | 1 |
| Vellenga, E | 1 |
| Karászi , E | 1 |
| Jakab, K | 1 |
| Homolya, L | 1 |
| Szakács, G | 1 |
| Holló, Z | 1 |
| Telek, B | 1 |
| Kiss, A | 1 |
| Rejtô, L | 1 |
| Nahajevszky, S | 1 |
| Sarkadi, B | 1 |
| Kappelmayer, J | 1 |
| Olson, DP | 1 |
| Taylor, BJ | 1 |
| Ivy, SP | 1 |
| Tsimberidou, AM | 1 |
| Paterakis, G | 1 |
| Androutsos, G | 1 |
| Anagnostopoulos, N | 1 |
| Galanopoulos, A | 1 |
| Kalmantis, T | 1 |
| Meletis, J | 1 |
| Rombos, Y | 1 |
| Sagriotis, A | 1 |
| Symeonidis, A | 1 |
| Tiniakou, M | 1 |
| Zoumbos, N | 1 |
| Yataganas, X | 1 |
| Engelhard, HH | 1 |
| Krupka, JL | 1 |
| Bauer, KD | 1 |
| Larsson, R | 1 |
| Nygren, P | 1 |
| Ekberg, M | 1 |
| Slater, L | 1 |
| Evans, CH | 1 |
| Heinbaugh, JA | 1 |
| Ransom, JH | 1 |
| Larrick, JW | 1 |
| Enns, C | 1 |
| Raubitschek, A | 1 |
| Weintraub, H | 1 |
| Zingde, SM | 1 |
| Anklesaria, PN | 1 |
| Advani, SH | 1 |
| Bhisey, AN | 1 |
| Gothoskar, BP | 1 |
| Finegold, I | 1 |
| Fahey, JL | 1 |
| Dutcher, TF | 1 |
| Takahashi, M | 1 |
| Tanigaki, N | 1 |
| Yagi, Y | 1 |
| Moore, GE | 1 |
| Pressman, D | 1 |
| Frank, RN | 1 |
| Ryan, SJ | 1 |
1 trial available for erythrosine and Leukemia, Myeloid
| Article | Year |
|---|---|
Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.
Topics: Acute Disease; Blood Proteins; Bone Marrow; Bone Marrow Cells; Carrier Proteins; Cell Division; Fluo | 1994 |
23 other studies available for erythrosine and Leukemia, Myeloid
| Article | Year |
|---|---|
PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biologica | 2002 |
APPLICATION OF IMMUNOFLUORESCENCE TO THE STUDY OF HUMAN LEUKEMIA.
Topics: Animals; Fluoresceins; Fluorescent Antibody Technique; Humans; Immune Sera; Leukemia; Leukemia, Lymp | 1964 |
Microfabricated system for parallel single-cell capillary electrophoresis.
Topics: Comet Assay; Electrophoresis, Capillary; Electrophoresis, Microchip; Fluoresceins; Fluorescent Dyes; | 2004 |
Lectin staining of carbohydrates of haemic cells; the cells of normal blood and bone marrow and of the myeloid leukaemias.
Topics: Aprotinin; Blood Cells; Bone Marrow; Carbohydrate Metabolism; Fluoresceins; Histocytochemistry; Huma | 1980 |
Peanut agglutinin: a marker for normal and leukaemic cells of the monocyte lineage.
Topics: Cell Differentiation; Cell Line; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Galac | 1982 |
Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O.
Topics: Bacterial Proteins; Base Sequence; Cell Line; Cell Membrane Permeability; Cell Nucleus; Cytoplasm; F | 1995 |
Novel fluoride-stimulated dichlorofluorescin dye oxidation pathway in human leukemia cell lines.
Topics: Cell Cycle; Cell Differentiation; Dimethylformamide; Flow Cytometry; Fluoresceins; Humans; Hydrogen | 1993 |
Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells.
Topics: Adenosine; Binding Sites; Carrier Proteins; Cell Line; Cytarabine; Fluoresceins; Humans; Leukemia, M | 1993 |
Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines.
Topics: Antioxidants; Apoptosis; Butylated Hydroxyanisole; Cycloheximide; Cytokines; Dose-Response Relations | 1996 |
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients.
Topics: Acute Disease; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette | 1998 |
Both P-gp and MRP contribute to drug resistance in AML.
Topics: Acute Disease; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-B | 1998 |
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, | 2000 |
Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia.
Topics: Acute Disease; Bone Marrow Cells; Cells, Cultured; Drug Resistance, Multiple; Female; Fluoresceins; | 2001 |
Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrate.
Topics: Child; DNA-Binding Proteins; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; Humans; Leukem | 2001 |
Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; | 2002 |
Simultaneous quantification of c-myc oncoprotein, total cellular protein, and DNA content using multiparameter flow cytometry.
Topics: Cell Cycle; Cell Line; Cells, Cultured; Cycloheximide; DNA; Flow Cytometry; Fluorescein-5-isothiocya | 1991 |
Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
Topics: Cell Count; Cell Survival; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluoresc | 1990 |
Flow cytometric evaluation of leukoregulin as an intrinsic molecular mediator of natural killer lymphocyte cytotoxicity.
Topics: Cell Line; Cell Membrane Permeability; Cytotoxicity, Immunologic; Flow Cytometry; Fluoresceins; Huma | 1987 |
Receptor-mediated endocytosis of human transferrin and its cell surface receptor.
Topics: Animals; Antibodies, Monoclonal; Cell Line; Cold Temperature; Endocytosis; Flow Cytometry; Fluoresce | 1985 |
Differential endocytosis of fluorescein iso-thiocyanate-concanavalin A by normal and chronic myeloid leukemic granulocytes.
Topics: Azides; Cell Differentiation; Cell Membrane; Colchicine; Concanavalin A; Cytochalasin B; Endocytosis | 1987 |
Immunofluorescent studies of immunoglobulins in human lymphoid cells in continuous culture.
Topics: Cellulose; Chemistry Techniques, Analytical; Culture Techniques; Fluoresceins; Fluorescent Antibody | 1968 |
Presence of two different immunoglobulin heavy chains in individual cells of established human hematopoietic cell lines.
Topics: Antibodies; Antigens; Bone Marrow; Bone Marrow Cells; Culture Media; Culture Techniques; Fluorescein | 1968 |
Peripheral retinal neovascularization with chronic myelogenous leukemia.
Topics: Adult; Blood Protein Electrophoresis; Diagnosis, Differential; Eye Diseases; Fluoresceins; Fundus Oc | 1972 |